223 related articles for article (PubMed ID: 16083705)
1. Mortality and hospital utilization for hepatocellular carcinoma in the United States.
Kim WR; Gores GJ; Benson JT; Therneau TM; Melton LJ
Gastroenterology; 2005 Aug; 129(2):486-93. PubMed ID: 16083705
[TBL] [Abstract][Full Text] [Related]
2. The inpatient economic and mortality impact of hepatocellular carcinoma from 2005 to 2009: analysis of the US nationwide inpatient sample.
Mishra A; Otgonsuren M; Venkatesan C; Afendy M; Erario M; Younossi ZM
Liver Int; 2013 Sep; 33(8):1281-6. PubMed ID: 23710596
[TBL] [Abstract][Full Text] [Related]
3. Mortality from hepatocellular and biliary cancers: changing epidemiological trends.
Nair S; Shiv Kumar K; Thuluvath PJ
Am J Gastroenterol; 2002 Jan; 97(1):167-71. PubMed ID: 11808943
[TBL] [Abstract][Full Text] [Related]
4. Hepatocellular Carcinoma: A Decade of Hospitalizations and Financial Burden in the United States.
Jinjuvadia R; Salami A; Lenhart A; Jinjuvadia K; Liangpunsakul S; Salgia R
Am J Med Sci; 2017 Oct; 354(4):362-369. PubMed ID: 29078840
[TBL] [Abstract][Full Text] [Related]
5. Treatment and outcomes of treating of hepatocellular carcinoma among Medicare recipients in the United States: a population-based study.
El-Serag HB; Siegel AB; Davila JA; Shaib YH; Cayton-Woody M; McBride R; McGlynn KA
J Hepatol; 2006 Jan; 44(1):158-66. PubMed ID: 16290309
[TBL] [Abstract][Full Text] [Related]
6. Hospitalizations and mortality in systemic sclerosis: results from the Nationwide Inpatient Sample.
Chung L; Krishnan E; Chakravarty EF
Rheumatology (Oxford); 2007 Dec; 46(12):1808-13. PubMed ID: 17986481
[TBL] [Abstract][Full Text] [Related]
7. Trends and outcomes of transarterial chemoembolization in hepatocellular carcinoma: a national survey.
Mumtaz K; Patel N; Modi RM; Patel V; Hinton A; Hanje J; Black SM; Krishna S
Hepatobiliary Pancreat Dis Int; 2017 Dec; 16(6):624-630. PubMed ID: 29291782
[TBL] [Abstract][Full Text] [Related]
8. Is fibrolamellar carcinoma different from hepatocellular carcinoma? A US population-based study.
El-Serag HB; Davila JA
Hepatology; 2004 Mar; 39(3):798-803. PubMed ID: 14999699
[TBL] [Abstract][Full Text] [Related]
9. Recent trends in inpatient mortality and resource utilization for patients with stroke in the United States: 2005-2009.
Stepanova M; Venkatesan C; Altaweel L; Mishra A; Younossi ZM
J Stroke Cerebrovasc Dis; 2013 May; 22(4):491-9. PubMed ID: 23545319
[TBL] [Abstract][Full Text] [Related]
10. Hepatocellular carcinoma: current management and recent advances.
Lau WY; Lai EC
Hepatobiliary Pancreat Dis Int; 2008 Jun; 7(3):237-57. PubMed ID: 18522878
[TBL] [Abstract][Full Text] [Related]
11. [Hepatocellular carcinoma].
Semela D; Heim M
Ther Umsch; 2011 Apr; 68(4):213-7. PubMed ID: 21452143
[TBL] [Abstract][Full Text] [Related]
12. Predictors and survival in hepatitis B-related hepatocellular carcinoma in New South Wales, Australia.
Nguyen VT; Amin J; Law MG; Dore GJ
J Gastroenterol Hepatol; 2009 Mar; 24(3):436-42. PubMed ID: 19175834
[TBL] [Abstract][Full Text] [Related]
13. Epidemiological trends of hepatocellular carcinoma in Austria.
Pinter M; Hucke F; Zielonke N; Trauner M; Sieghart W; Peck-Radosavljevic M
Dig Dis; 2014; 32(6):664-9. PubMed ID: 25376282
[TBL] [Abstract][Full Text] [Related]
14. The burden of appendicitis-related hospitalizations in the United States in 1997.
Davies GM; Dasbach EJ; Teutsch S
Surg Infect (Larchmt); 2004; 5(2):160-5. PubMed ID: 15353112
[TBL] [Abstract][Full Text] [Related]
15. Novel population-based study finding higher than reported hepatocellular carcinoma incidence suggests an updated approach is needed.
Hong TP; Gow P; Fink M; Dev A; Roberts S; Nicoll A; Lubel J; Kronborg I; Arachchi N; Ryan M; Kemp W; Knight V; Farrugia H; Thursfield V; Desmond P; Thompson AJ; Bell S
Hepatology; 2016 Apr; 63(4):1205-12. PubMed ID: 26435297
[TBL] [Abstract][Full Text] [Related]
16. Trends and predictors of outcomes after surgery for hepatocellular carcinoma: A nationwide population-based study in Taiwan.
Chiu CC; Wang JJ; Chen YS; Chen JJ; Tsai TC; Lai CC; Sun DP; Shi HY
Eur J Surg Oncol; 2015 Sep; 41(9):1170-8. PubMed ID: 26048295
[TBL] [Abstract][Full Text] [Related]
17. Health care costs associated with hepatocellular carcinoma: a population-based study.
Thein HH; Isaranuwatchai W; Campitelli MA; Feld JJ; Yoshida E; Sherman M; Hoch JS; Peacock S; Krahn MD; Earle CC
Hepatology; 2013 Oct; 58(4):1375-84. PubMed ID: 23300063
[TBL] [Abstract][Full Text] [Related]
18. The burden of illness associated with hepatocellular carcinoma in the United States.
Lang K; Danchenko N; Gondek K; Shah S; Thompson D
J Hepatol; 2009 Jan; 50(1):89-99. PubMed ID: 18977551
[TBL] [Abstract][Full Text] [Related]
19. Factors that affect risk for hepatocellular carcinoma and effects of surveillance.
Yang JD; Harmsen WS; Slettedahl SW; Chaiteerakij R; Enders FT; Therneau TM; Orsini L; Kim WR; Roberts LR
Clin Gastroenterol Hepatol; 2011 Jul; 9(7):617-23.e1. PubMed ID: 21459158
[TBL] [Abstract][Full Text] [Related]
20. Female gender increases the risk of death during hospitalization for pediatric cardiac surgery.
Seifert HA; Howard DL; Silber JH; Jobes DR
J Thorac Cardiovasc Surg; 2007 Mar; 133(3):668-75. PubMed ID: 17320563
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
